DE69614105D1 - Lagerstabile hämoglobinlösungen - Google Patents

Lagerstabile hämoglobinlösungen

Info

Publication number
DE69614105D1
DE69614105D1 DE69614105T DE69614105T DE69614105D1 DE 69614105 D1 DE69614105 D1 DE 69614105D1 DE 69614105 T DE69614105 T DE 69614105T DE 69614105 T DE69614105 T DE 69614105T DE 69614105 D1 DE69614105 D1 DE 69614105D1
Authority
DE
Germany
Prior art keywords
hemoglobin solutions
storage
solutions
storage stable
stable hemoglobin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69614105T
Other languages
English (en)
Other versions
DE69614105T2 (de
Inventor
A Kerwin
L Looker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Biotech Technology SARL
Original Assignee
Baxter Biotech Technology SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Biotech Technology SARL filed Critical Baxter Biotech Technology SARL
Application granted granted Critical
Publication of DE69614105D1 publication Critical patent/DE69614105D1/de
Publication of DE69614105T2 publication Critical patent/DE69614105T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
DE69614105T 1995-05-02 1996-05-01 Lagerstabile hämoglobinlösungen Expired - Lifetime DE69614105T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/433,896 US5929031A (en) 1995-05-02 1995-05-02 Storage stable hemoglobin solutions
PCT/US1996/006080 WO1996034889A1 (en) 1995-05-02 1996-05-01 Storage stable hemoglobin solutions

Publications (2)

Publication Number Publication Date
DE69614105D1 true DE69614105D1 (de) 2001-08-30
DE69614105T2 DE69614105T2 (de) 2002-03-21

Family

ID=23721974

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69614105T Expired - Lifetime DE69614105T2 (de) 1995-05-02 1996-05-01 Lagerstabile hämoglobinlösungen

Country Status (7)

Country Link
US (1) US5929031A (de)
EP (1) EP0826004B1 (de)
JP (1) JPH11507016A (de)
AT (1) ATE203546T1 (de)
CA (1) CA2216382A1 (de)
DE (1) DE69614105T2 (de)
WO (1) WO1996034889A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242417B1 (en) * 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US6288027B1 (en) 1995-03-23 2001-09-11 Biopure Corporation Preserving a hemoglobin blood substitute with a transparent overwrap
US6610832B1 (en) 1995-03-23 2003-08-26 Biopure Corporation Preserving a hemoglobin blood substitute with a transparent overwrap
US6271351B1 (en) 1995-03-23 2001-08-07 Biopure Corporation Method for preserving a hemoglobin blood substitute
US5981710A (en) * 1997-07-21 1999-11-09 Baxter International, Inc. Therapeutic hemoglobin composition having isotropically increased size
US6018035A (en) * 1997-07-21 2000-01-25 Baxter International Inc. Reagents for isotropic size enhancement of a peptide, protein, nucleotide or other substrate
US6204254B1 (en) 1997-09-12 2001-03-20 Baxter International, Inc. Biocompatible surfaces and a method for their preparation
WO2001002438A1 (fr) * 1999-07-01 2001-01-11 International Reagents Corporation Moyens pour stabiliser les hemoglobines
JP3466516B2 (ja) * 1999-09-07 2003-11-10 科学技術振興事業団 安定保存可能な酸素輸液剤
US6894150B1 (en) 1999-10-01 2005-05-17 Ross Walden Tye Non-pyrogenic, endotoxin-free, stroma-free tetrameric hemoglobin
US6949384B2 (en) * 2001-12-21 2005-09-27 Spectromedical Inc. Method for monitoring degradation of Hb-based blood substitutes
US7449339B2 (en) * 1999-11-23 2008-11-11 Nir Diagnostics Inc. Spectroscopic method and apparatus for total hemoglobin measurement
FR2809624B1 (fr) * 2000-05-31 2002-08-02 Centre Nat Rech Scient Utilisation comme substitut sanguin d'une hemoglobine extracellulaire de poids moleculaire eleve
US6974447B2 (en) * 2001-04-17 2005-12-13 Baxter International Inc. High gas barrier receptacle and closure assembly
KR20030097834A (ko) * 2001-04-18 2003-12-31 노쓰필드 라보라토리스, 인코포레이티드 안정화된 헤모글로빈 용액을 저장하기 위한 가요성 용기시스템
US7747315B2 (en) * 2002-01-15 2010-06-29 Board Of Regents, The University Of Texas System Methods and compositions to reduce scattering of light during therapeutic and diagnostic imaging procedures
US20050260259A1 (en) * 2004-04-23 2005-11-24 Bolotin Elijah M Compositions for treatment with glucagon-like peptide, and methods of making and using the same
US7635463B2 (en) 2002-02-27 2009-12-22 Pharmain Corporation Compositions for delivery of therapeutics and other materials
DE60335608D1 (de) * 2002-02-27 2011-02-17 Pharmain Corp Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung
CA2492143A1 (en) * 2002-07-12 2004-01-22 Medarex, Inc. Methods and compositions for preventing oxidative degradation of proteins
US7223604B1 (en) * 2002-09-27 2007-05-29 Science & Technology Corporation @ Unm Methods and kits for the detection of erythrocytes
BRPI0407106A (pt) * 2003-01-29 2006-01-24 Northfield Lab Soluções de hemoglobina polimerizadas com quantidade reduzida de tetrâmero e método para preparação
JP2006164312A (ja) * 2004-12-02 2006-06-22 Hitachi Ltd 半導体装置およびそれを用いた磁気記録再生装置
AU2006220548B2 (en) * 2005-03-07 2011-04-21 Sangart, Inc. Composition and methods for delivering carbon monoxide (CO) and nitric ozide (NO) CO to tissue using heme proteins as carriers
EP1978802A2 (de) * 2006-01-24 2008-10-15 Northfield Laboratories, Inc. Polymerisiertes hämoglobinmedium und verwendung davon bei der isolierung und transplantation von inselzellen
US20090004159A1 (en) * 2006-01-24 2009-01-01 The Board Of Trustees Of The University Of Illinoi Polymerized Hemoglobin Media and Its Use in Isolation and Transplantation of Islet Cells
US7504377B2 (en) * 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
US7494974B2 (en) * 2006-10-24 2009-02-24 Ikor, Inc. Carboxymethylated cross-linked tetrameric hemoglobin
JP2008195656A (ja) * 2007-02-14 2008-08-28 Nipro Corp 人工酸素運搬体製剤
US8609815B2 (en) 2010-09-02 2013-12-17 Sangart, Inc. Methods for preparing stable deoxygenated PEG-hemoglobin conjugate solutions comprising an antioxidant
CA2860158A1 (en) * 2011-01-07 2012-07-12 Somerset Group Enterprises, Inc. Modular extracorporeal systems and methods for treating blood-borne diseases
US9375525B2 (en) 2012-01-09 2016-06-28 Somerset Group Enterprises, Inc. Modular extracorporeal systems and methods for treating blood-borne diseases
US9763889B2 (en) * 2015-06-29 2017-09-19 Billion King International Ltd. Oral delivery system for hemoglobin based oxygen carriers
US10052290B2 (en) * 2016-02-04 2018-08-21 Billion King International Ltd. Enteric-coated hemoglobin multiparticulate for oral delivery of hemoglobin based oxygen carriers
EP4133285A1 (de) * 2020-04-09 2023-02-15 Institut National de la Santé et de la Recherche Médicale (INSERM) Verfahren und zusammensetzungen zur bestimmung der qualität von einheiten roter blutkörperchen

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3144705C2 (de) * 1981-11-11 1983-12-08 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung eines lagerstabilen, vernetzten Hämoglobinpräparates mit hoher Sauerstoff-Transportkapazität, sowie das nach diesem Verfahren hergestellte Hämoglobinpräparat
US4727027A (en) * 1983-05-02 1988-02-23 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
US4861867A (en) * 1988-02-03 1989-08-29 Baxter International, Inc. Purified hemoglobin solutions and method for making same
US5234903A (en) * 1989-11-22 1993-08-10 Enzon, Inc. Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
US5352773A (en) * 1990-08-06 1994-10-04 Baxter International Inc. Stable hemoglobin based composition and method to store same
JP2709419B2 (ja) * 1990-08-06 1998-02-04 バクスター、インターナショナル、インコーポレイテッド 安定なヘモグロビンに基づく組成物及びその貯蔵方法
AU9067791A (en) * 1990-11-20 1992-06-11 Enzon, Inc. Method of enhancing long-term storage stability of hemoglobin products
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation

Also Published As

Publication number Publication date
WO1996034889A1 (en) 1996-11-07
DE69614105T2 (de) 2002-03-21
JPH11507016A (ja) 1999-06-22
US5929031A (en) 1999-07-27
EP0826004A1 (de) 1998-03-04
AU5852096A (en) 1996-11-21
EP0826004B1 (de) 2001-07-25
CA2216382A1 (en) 1996-11-07
AU708264B2 (en) 1999-07-29
ATE203546T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
DE69614105T2 (de) Lagerstabile hämoglobinlösungen
MY128485A (en) Pesticidal 1-arylpyrazoles
BG104247A (en) Resorcinol derivatives
TNSN96165A1 (fr) Nouveaux pesticides.
HK1041521B (zh) 生長不同因素抑制劑及其用途
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
ITMI941891A0 (it) 3-aril-benzofuranoni come agenti stabilizzanti
ATE291917T1 (de) Topisch anzuwendende ketoconazol enthaltende emulsionen
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
GR3025485T3 (en) Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
BG106681A (en) Solutions containing epinastine
EP0671911A4 (de) Carboxypeptidyl-derivate als antidegenerative wirkstoffe.
IL147676A0 (en) Improvement of spermatozoa fertilization activity
ES2096497T3 (es) Procedimiento para la obtencion de aminoalcoholes opticamente activos.
FR2742048B1 (fr) Utilisation de l'alpha-cyano-beta, beta-diphenylacrylate de 2-ethylhexyle pour ameliorer la stabilite de compositions cosmetiques contenant le p-methyl-benzylidene camphre en association avec un derive de dibenzoylmethane
DE69905468D1 (de) Sporizide zusammensetzung
GR3002981T3 (en) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1h-imidazole
ATE222103T1 (de) Inklusionskomplexe in waessriger loesung
ATE179075T1 (de) Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine
DK0713485T3 (da) Thiocarbamoylforbindelser som mikrobicider
ES2116399T3 (es) Derivados tiazolicos de alcoxiacrilatos con una actividad fungicida.
IL147223A0 (en) The use of the protein uk 114 for inhibiting organ transplant rejection
MX9802272A (es) Combate contra hongos parasitos con una combinacion de un agente activo que inhibe la respiracion en el complejo iii de citocromo y de fenazaquina.
MX9801683A (es) Composiciones y metodos para controlar hongos perjudiciales.
ES2065844A1 (es) Aplicacion de ent-16,18-dihidroxi-6-oxo-oxido de manoilo como inhibidor de la adenilatociclasa.